Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welen, Ebba Rosendal, Magnus Gisslen, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93. Positive Effects of Enzalutamide for Hospitalized COVID-19 PatientsShow others and affiliations
2022 (English)In: European Urology, ISSN 0302-2838, E-ISSN 1873-7560, Vol. 81, no 6, p. E143-E144Article in journal, Letter (Other academic) Published
Place, publisher, year, edition, pages
Elsevier BV Elsevier, 2022. Vol. 81, no 6, p. E143-E144
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:uu:diva-482413DOI: 10.1016/j.eururo.2022.02.016ISI: 000831850300002PubMedID: 35248411OAI: oai:DiVA.org:uu-482413DiVA, id: diva2:1689819
2022-08-242022-08-242025-02-18Bibliographically approved